Julie Lange

Medicine & Life Sciences

1. Melanoma 100%
2. Breast Neoplasms 47%
3. Guidelines 34%
4. Sentinel Lymph Node Biopsy 32%
5. Breast 28%
6. Lymph Node Excision 24%
7. Neoplasms 24%
8. Sentinel Lymph Node 21%
9. Methylation 18%
10. Skin 18%
11. Interleukin-2 15%
12. Therapeutics 12%
13. Practice Guidelines 12%
14. Immunotherapy 11%
15. Cyclophosphamide 11%
16. Therapeutic Irrigation 11%
17. Polymerase Chain Reaction 10%
18. Epidemiology 9%
19. Survival 9%
20. Recurrence 9%
21. Biomarkers 8%
22. Amelanotic Melanoma 8%
23. Interleukin-1 8%
24. Vorinostat 8%
25. liposomal doxorubicin 8%
26. Neoplasm Metastasis 8%
27. Artificial Intelligence 7%
28. taxane 7%
29. Neoplasm Micrometastasis 7%
30. Crystalloid Solutions 7%
31. Drug Therapy 7%
32. Doxorubicin 7%
33. Nipples 7%
34. Trastuzumab 7%
35. Colloids 6%
36. Large-Core Needle Biopsy 6%
37. Neuroendocrine Tumors 6%
38. Radiotherapy 6%
39. Needle Biopsy 6%
40. Somatostatin 6%
41. Mastectomy 6%
42. Peritonitis 6%
43. Oliguria 6%
44. Fine Needle Biopsy 6%
45. Histology 6%
46. Endotoxins 5%
47. Cyclin D2 5%
48. Genes 5%